Mei Wu

SGLT2 inhibitors for heart failure outcomes across baseline glycemic status: a systematic review and stratified meta-analysis of independent parent trial populations

Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve heart failure outcomes, but whether relative effects are consistent across normoglycemia, prediabetes, and diabetes/type 2 diabetes remains uncertain. Linked publications from the same randomized populations may also be do...